Results 11 to 20 of about 5,272 (205)

HHV8-Negative Primary Effusion Lymphoma of B-Cell Lineage: Two Cases and a Comprehensive Review of the Literature [PDF]

open access: yesCase Reports in Oncological Medicine, 2013
Primary effusion lymphoma (PEL) is a rare extranodal lymphoma that typically presents in a body cavity in the absence of a detectable tumor mass and that occurs predominantly in immunosuppressed individuals.
Neeraj Saini   +5 more
doaj   +2 more sources

HHV8 and EBV‐negative primary effusion‐based lymphoma: A case report of a new provisional entity and review of literature [PDF]

open access: yesClinical Case Reports, 2023
Key Clinical Message HHV8‐ and EBV‐negative primary effusion lymphoma is an extremely rare neoplasm involving body cavities without detectable tumor mass. It usually presents in elderly patients without known immunodeficiency.
Marta Canelo‐Vilaseca   +11 more
doaj   +2 more sources

A Review of KSHV/HHV8-Associated Neoplasms and Related Lymphoproliferative Lesions

open access: yesLymphatics
There has been extensive research on the KSHV/HHV8 virus, which has led to a better understanding of viral transmission, pathogenesis, viral-driven lymphoid proliferation, neoplastic transformation, and how we might combat these processes clinically.
Jamie Rigney   +3 more
doaj   +2 more sources

HHV8/EBV Coinfection Lymphoproliferative Disorder: Rare Entity with a Favorable Outcome [PDF]

open access: yesCase Reports in Hematology, 2017
HHV8/EBV-associated germinotropic lymphoproliferative disorder (GLD) is a challenging diagnosis given its rarity, the particular clinical presentation, and the lack of expression of markers usually used in establishing hematopoietic lineage.
Dhouha Bacha   +6 more
doaj   +2 more sources

Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma. [PDF]

open access: yesPLoS Pathogens, 2012
The contribution of innate immunity to immunosurveillance of the oncogenic Human Herpes Virus 8 (HHV8) has not been studied in depth. We investigated NK cell phenotype and function in 70 HHV8-infected subjects, either asymptomatic carriers or having ...
Stéphanie Dupuy   +7 more
doaj   +2 more sources

HHV8-positive multicentric Castleman’s disease and thrombotic thrombocytopenic purpura among HIV-positive patients [PDF]

open access: yesEuropean Journal of Case Reports in Internal Medicine
Castleman’s disease (CD) and thrombotic thrombocytopenic purpura (TTP) are rare diseases that can affect the general population, especially those with HIV. Owing to their rarity, the association between CD and TTP remains insufficiently understood.
Roxane Pasquer   +5 more
doaj   +2 more sources

Absence of human herpes virus-8 (HHV8) in nephrogenic systemic fibrosis [PDF]

open access: yesBMC Research Notes, 2008
Background Nephrogenic systemic fibrosis (NSF) is a fibrosing disorder that exhibits CD34 expression in the majority of lesional spindle cells. Several features of NSF bear similarity to Kaposi sarcoma.
Pantanowitz Liron   +2 more
doaj   +2 more sources

HHV8-Associated Multicentric Castleman Disease: A Case Report on a Rare Complication of HIV in a Low-Income Setting [PDF]

open access: yesResearch and Reports in Tropical Medicine
Marcus Ground,1 Thijmen Veenendaal,1 Daniel Rexie Chiluzi,1 Geoffrey Nkhonjera,2 Arie C Glas,1 Lisanne Glas-van Dijk1 1Mulanje Mission Hospital, Mulanje, Malawi; 2Oncology Department, Queen Elizabeth Central Hospital, Blantyre, MalawiCorrespondence ...
Ground M   +5 more
doaj   +1 more source

Deciphering the full spectrum of Castleman diseases based on a cohort of 700 patients in a western country. [PDF]

open access: yesBr J Haematol
The spectrum of Castleman diseases has expanded over the past three decades. The phenotype of the diseases varies not only among the three major types but also according to the patient ancestry. Summary Under the Castleman disease (CD) eponym, three distinct diseases sharing common pathological features have been described over time.
Oksenhendler E   +4 more
europepmc   +2 more sources

Prevention of Oncogenic Gammaherpesvirinae (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients. [PDF]

open access: yes, 2023
Long-term risk for malignancy is higher among solid organ transplant (SOT) recipients compared to the general population. Four non-hepatitis viruses have been recognized as oncogenic in SOT recipients-EBV, cause of EBV-associated lymphoproliferative ...
Hirzel, Cédric   +2 more
core   +3 more sources

Home - About - Disclaimer - Privacy